Our providers will guide you in monitoring your blood glucose levels closely during this period and make adjustments as needed
For testing laboratories, SELECT established that Wegovys cardiovascular indication requires the same rigorous GLP-1 receptor agonist quality testing as other cardiovascular drugs, including the monitoring of immunogenicity and biomarkers that could affect CV outcomes
This is why baseline evaluation with your neurologist is essential before starting any GLP-1 therapy
Prior authorizations can be filed starting now (they could not be submitted before July 1)
P., Kalagara, S., AlvarezCespedes, D., Sechi, A., & Tosti, A
To validate our findings, we set out to replicate them in the real-world data of the All of Us Research Program